Merial is a world-leading animal healthcare company with a global total market share of more than 14 percent.

An innovation-driven leader, Merial makes significant investments in research and development, with ten research and development centers around the world. Merial is committed to developing pharmaceuticals and vaccines with the highest level of quality, safety and efficacy through an extensive network of 16 manufacturing sites.

Merial provides a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. We play a pioneering role with governments around the globe to contain and manage various animal diseases—recognizing that the prevention and cure of animal diseases are in the interests of protecting the health of animals and of man.

Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs approximately 5600 people and operates in more than 150 countries worldwide. Its 2010 sales were over $2.6 billion. Merial is the animal health division of sanofi-aventis.

Merial is committed to enhancing the health, well-being and performance of animals. Our strengths in parasite control and disease prevention are known around the world. Many Merial products are considered gold standards in their categories. For example, FRONTLINE® brand products have achieved success as the undisputed leader in flea and tick control.